Virginia Maria Radulescu

Dr. Virginia Maria Radulescu

University of Craiova, Craiova, Dolj, Romania
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
CMCamelia Adela Maican
Camelia Adela Maican
Cristina Floriana PanaCristina Floriana Pana
Cristina Floriana Pana
DPDaniela Maria Pătrașcu-Pană
Daniela Maria Pătrașcu-Pană
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
Fault detection and diagnosis (FDD) in power plant systems is a rapidly evolving field driven by the increasing complexity of industrial infrastructure and the demand for reliability, safety, and predictive maintenance. This review presents a structured and data-driven synthesis of 185 peer-reviewed articles, sourced from journals indexed in MDPI and Elsevier, as well as through the Google Scholar search engine, published between 2019 and 2025. The study systematically classifies these articles by plant type, sensor technology, algorithm category, and diagnostic pipeline (detection, localization, resolution). The analysis reveals a significant transition from traditional statistical methods to machine learning (ML) and deep learning (DL) models, with over 70% of recent studies employing AI-driven approaches. However, only 30.3% of the articles addressed the full diagnostic pipeline and merely 17.3% targeted system-level faults. Most research remains component-focused and lacks real-world validation or interpretability. A novel taxonomy of diagnostic configurations, mapping system types, sensor use, algorithmic strategy, and functional depth is proposed. In addition, a methodological checklist is introduced to evaluate the completeness and operational readiness of FDD studies. Key findings are summarized in a comparative matrix, highlighting trends, gaps, and inconsistencies across publication sources. This review identifies critical research gaps—including the underuse of hybrid models, lack of benchmark datasets, and limited integration between detection and control layers—and offers concrete recommendations for future research. Combining a thematic and quantitative approach, this article aims to support researchers, engineers, and decision-makers in developing more robust, scalable, and transparent diagnostic systems for power generation infrastructure.

31 January 2025 in Life
Verified
Journal Article
Open access
PDF file
Maria-Lorena MustataMaria-Lorena Mustata
Maria-Lorena Mustata
CNCarmen Daniela Neagoe
Carmen Daniela Neagoe
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
IDIoana-Gabriela Dragne
Ioana-Gabriela Dragne
RCRadu Cristian Cimpeanu
Radu Cristian Cimpeanu
Simona Laura IanoșiSimona Laura Ianoși
Simona Laura Ianoși
Background/objectives: Psoriasis is a chronic inflammatory autoimmune disease with important systemic and psychosocial impacts. The association with metabolic syndrome (MS) impairs disease severity and negatively influences patient-reported outcomes, particularly their quality of life as measured by the Dermatology Life Quality Index (DLQI). This study aims to investigate the relationship between systemic inflammation, DLQI scores and disease severity, focusing on the persistent impact of MS on patient outcomes after one year of treatment. Methods: This retrospective cross-sectional study included 150 psoriasis patients, with 74 also meeting the diagnostic criteria for MS. Clinical and inflammatory markers such as systemic immune–inflammatory index (SII), cytokines (IL-17A, IL-23), leptin, BMI and triglycerides were analyzed alongside PASI and DLQI scores. Results: Patients with MS had significantly higher PASI and DLQI scores compared to those without MS, reflecting worse disease severity and quality of life (p < 0.01). Elevated SII levels were strongly associated with higher DLQI scores (p < 0.01). Despite considerable reductions in PASI scores over one year of treatment, DLQI scores indicated a persistent negative impact of MS on quality of life. Notably, markers of systemic inflammation, such as SII, leptin and cytokines, correlated positively with both PASI and DLQI scores, highlighting the role of systemic inflammation in disease burden. Conclusions: This study underlines the significant role of systemic inflammation and metabolic comorbidities in amplifying the burden of psoriasis. The persistent impact of MS on quality of life despite clinical improvement underscores the need for comprehensive treatment approaches targeting systemic inflammation, metabolic health and psychosocial factors to improve long-term outcomes.

3 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Maria-Lorena MustataMaria-Lorena Mustata
Maria-Lorena Mustata
CNCarmen Daniela Neagoe
Carmen Daniela Neagoe
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
IDIoana-Gabriela Dragne
Ioana-Gabriela Dragne
RCRadu Cristian Cimpeanu
Radu Cristian Cimpeanu
Simona Laura IanoșiSimona Laura Ianoși
Simona Laura Ianoși
Background/Objectives: Psoriasis is a chronic inflammatory autoimmune disease with important systemic and psychosocial impacts. The association with metabolic syndrome (MS) impairs disease severity and negatively influences patient-reported outcomes, particularly their quality of life as measured by the Dermatology Life Quality Index (DLQI). This study aims to investigate the relationship between systemic inflammation, DLQI scores, and disease severity, focusing on the persistent impact of MS on patient outcomes after one year of treatment. Methods: This retrospective cross-sectional study included 150 psoriasis patients, with 74 also meeting the diagnostic criteria for MS. Clinical and inflammatory markers such as systemic immune-inflammatory index (SII), cytokines (IL-17A, IL-23), leptin, BMI, and triglycerides were analyzed alongside PASI and DLQI scores. Results: Patients with MS had significantly higher PASI and DLQI scores compared to those without MS, reflecting worse disease severity and quality of life (p < 0.001). Elevated SII levels were strongly associated with higher DLQI scores (p < 0.0001). Despite considerable reductions in PASI scores over one year of treatment, DLQI scores indicated a persistent negative impact of MS on quality of life. Notably, markers of systemic inflammation, such as SII, leptin, and cytokines, correlated positively with both PASI and DLQI scores, highlighting the role of systemic inflammation in disease burden. Conclusions: This study underlines the significant role of systemic inflammation and metabolic comorbidities in amplifying the burden of psoriasis. The persistent impact of MS on quality of life despite clinical improvement underscores the need for comprehensive treatment approaches targeting systemic inflammation, metabolic health, and psychosocial factors to improve long-term outcomes.

8 June 2026 in Sensors
Verified
Journal Article
Open access
PDF file
Cristina Floriana PanaCristina Floriana Pana
Cristina Floriana Pana
CMCamelia Adela Maican
Camelia Adela Maican
NVNicolae-Răzvan Vrăjitoru
Nicolae-Răzvan Vrăjitoru
DPDaniela Maria Pătrașcu-Pană
Daniela Maria Pătrașcu-Pană
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
Multimodal sensor fusion is increasingly used to improve observability for fault diagnosis and prognostics, enabling Remaining Useful Life estimation in complex mechatronic and robotic systems. Yet, real-world deployments remain vulnerable to sensor faults and data integrity issues—including bias and drift, miscalibration, dropouts, saturation, cross-talk, time desynchronization, and domain shift—which can propagate through fusion pipelines and lead to optimistic validation and poor generalization. These challenges are particularly consequential in safety- and health-adjacent applications such as collaborative robots, wearable/rehabilitation devices, and human-centric mechatronic systems where decisions based on faulty sensing may affect both reliability and user safety. This review synthesizes the state of the art on (i) sensor fault taxonomies and fault models relevant to multimodal fusion, (ii) fault-aware fusion strategies spanning data-, feature-, and decision-level integration, and (iii) how sensor faults and uncertainty impact diagnosis and remaining-life estimators. We will conduct a systematic scoping review of peer-reviewed literature, extracting sensor modalities, fault characterization or injection protocols, fusion architectures, validation settings (simulation, hardware-in-the-loop, bench, and in-field/on-body studies), and reporting completeness. Beyond summarizing methods, we provide practical reporting standards for sensor-fusion-based diagnosis and prognostics, including a minimum disclosure set covering synchronization, fault ground truth, missingness handling, leakage controls, uncertainty calibration, and task-relevant metrics. Reusable checklists and evidence tables are included to support more comparable, reproducible, and deployment-ready research.

7 July 2023 in Sensors
Verified
Journal Article
Open access
PDF file
Cristina Floriana PanaCristina Floriana Pana
Cristina Floriana Pana
DPDorin Popescu
Dorin Popescu
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
Robotic systems for lower limb rehabilitation are essential for improving patients’ physical conditions in lower limb rehabilitation and assisting patients with various locomotor dysfunctions. These robotic systems mainly integrate sensors, actuation, and control systems and combine features from bionics, robotics, control, medicine, and other interdisciplinary fields. Several lower limb robotic systems have been proposed in the patent literature; some are commercially available. This review is an in-depth study of the patents related to robotic rehabilitation systems for lower limbs from the point of view of the sensors and actuation systems used. The patents awarded and published between 2013 and 2023 were investigated, and the temporal distribution of these patents is presented. Our results were obtained by examining the analyzed information from the three public patent databases. The patents were selected so that there were no duplicates after several filters were used in this review. For each patent database, the patents were analyzed according to the category of sensors and the number of sensors used. Additionally, for the main categories of sensors, an analysis was conducted depending on the type of sensors used. Afterwards, the actuation solutions for robotic rehabilitation systems for upper limbs described in the patents were analyzed, highlighting the main trends in their use. The results are presented with a schematic approach so that any user can easily find patents that use a specific type of sensor or a particular type of actuation system, and the sensors or actuation systems recommended to be used in some instances are highlighted.

11 November 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Vlad PadureanuVlad Padureanu
Vlad Padureanu
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
CMCristiana Moise
Cristiana Moise
MMMarius Cristian Marinaș
Marius Cristian Marinaș
Padureanu RodicaPadureanu Rodica
Padureanu Rodica
BLBOLDEANU LIDIA
BOLDEANU LIDIA
Background/Objectives: Oxidative stress contributes to the pathogenesis of cirrhosis, but its value as a clinical biomarker remains uncertain. Methods: We retrospectively analysed 90 patients with decompensated cirrhosis. Serum malondialdehyde (MDA) and 8-epi-prostaglandin F2α (8-iso-PGF2α) were measured at admission. Biomarker levels were compared between Child–Pugh classes B and C, across hepatic encephalopathy grades, and ascites severity, using Mann–Whitney, Kruskal–Wallis, and Spearman correlation tests. Results: Median MDA did not differ significantly between Child–Pugh classes B and C (2.67 [2.10–3.20] vs. 2.45 [1.98–3.05] μmol/L; p = 0.331), nor across ascites categories (p = 0.453). Similarly, 8-iso-PGF2α values did not vary between Child–Pugh classes (255.8 [220.0–310.0] vs. 250.1 [210.0–295.0] pg/mL; p = 0.784) or ascites groups (p = 0.828). Spearman analysis showed no significant correlations with albumin, INR, bilirubin, creatinine, or age, except for a non-significant trend with bilirubin (ρ = −0.18, p = 0.09). Importantly, MDA levels increased significantly across encephalopathy grades (p = 0.021), suggesting a link between systemic oxidative stress and neuropsychiatric impairment. Conclusions: In this clinical cohort, oxidative stress biomarkers did not provide discriminatory value for staging by Child–Pugh or ascites, but MDA was associated with encephalopathy severity. These findings highlight both the limitations and potential clinical relevance of oxidative stress markers in cirrhosis management.